Search

everythinglearnresearchcommunity

for

Search:↓

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

A rare ovarian tumor caused hair loss in a post-menopausal woman, which almost completely stopped after surgery.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Menopause affects hair and skin; more research needed for treatment.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.